Relative contribution of clinical and molecular features to outcome within low and high risk T and N groups in stage III colon cancer (CC).

Authors

null

Frank A. Sinicrope

Mayo Clinic, Rochester, MN

Frank A. Sinicrope , Lucas J. Huebner , Pierre Laurent-Puig , Thomas C. Smyrk , Josep Tabernero , Enrico Mini , Richard M. Goldberg , Gunnar Folprecht , Aziz Zaanan , Karine Le Malicot , Qian Shi , Steven R Alberts , Julien Taieb

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3520)

DOI

10.1200/JCO.2019.37.15_suppl.3520

Abstract #

3520

Poster Bd #

12

Abstract Disclosures